TipRanks
Aclaris Therapeutics (DE:8AT)
FRANKFURT:8AT

Compare Aclaris Therapeutics (8AT) vs. Competitors

1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Aclaris Therapeutics
€5.29
€521.50M
-6.84
74.29%
7 Buy
0 Hold
0 Sell
Strong Buy
Omeros
$18.22
$1.33B
9.65
145.21%
2 Buy
1 Hold
0 Sell
Moderate Buy
Rigel
$46.75
$958.46M
2.90
62.27%
2 Buy
2 Hold
0 Sell
Moderate Buy
Galectin Therapeutics
$4.15
$334.82M
-7.78
-34.52%
1 Buy
0 Hold
0 Sell
Moderate Buy
MiMedx Group
$4.34
$566.19M
-29.96
-47.57%
4 Buy
0 Hold
0 Sell
Strong Buy
Replimune Group
$15.80
$1.67B
-6.31
71.80%
7 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:8AT
Aclaris Therapeutics
3.44
1.23
55.77%
OMER
Omeros
18.44
11.27
157.18%
RIGL
Rigel
51.31
20.66
67.41%
GALT
Galectin Therapeutics
3.32
-2.68
-44.67%
MDXG
MiMedx Group
3.88
-3.64
-48.40%
REPL
Replimune Group
17.61
8.31
89.25%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts